The War on Cancer An Anatomy of Failure, A Blueprint for the Future /

After reviewing the history of cancer and its impact on the population, Dr. Faguet exposes the antiquated notions that have driven cancer drug development, documents the stagnation in treatment outcomes despite major advances in cancer genomics and growing NCI budgets, and identifies the multiple fa...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας: Faguet, Guy B. (Συγγραφέας)
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Dordrecht : Springer Netherlands, 2005.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03058nam a22004935i 4500
001 978-1-4020-3617-0
003 DE-He213
005 20151204180040.0
007 cr nn 008mamaa
008 100301s2005 ne | s |||| 0|eng d
020 |a 9781402036170  |9 978-1-4020-3617-0 
024 7 |a 10.1007/978-1-4020-3617-0  |2 doi 
040 |d GrThAP 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
082 0 4 |a 614.5999  |2 23 
100 1 |a Faguet, Guy B.  |e author. 
245 1 4 |a The War on Cancer  |h [electronic resource] :  |b An Anatomy of Failure, A Blueprint for the Future /  |c by Guy B. Faguet. 
264 1 |a Dordrecht :  |b Springer Netherlands,  |c 2005. 
300 |a XV, 227 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Cancer Statistics: Some Facts -- Assessing the magnitude of the problem -- The problem is growing, not going away -- What Is Cancer? -- Cancer through the ages -- Our current understanding -- How Is Cancer Treated? -- The cancer cell-kill paradigm and its corollaries -- Chemotherapy drugs -- Treatment outcomes: Dismal by any standard -- Why Does This System Persist? -- The role of the National Cancer Institute -- Publications: The facts and nothing but the facts? -- From the doctors' perspective -- From the patients' perspective -- Where Do We Go From Here? -- A vision for the future -- Shifting from the cell-kill paradigm to pharmacogenomics. 
520 |a After reviewing the history of cancer and its impact on the population, Dr. Faguet exposes the antiquated notions that have driven cancer drug development, documents the stagnation in treatment outcomes despite major advances in cancer genomics and growing NCI budgets, and identifies the multiple factors that sustain the status quo. He shows that, contrary to frequent announcements of breakthroughs, our current cancer control model cannot eradicate most cancers and the reasons why. Significantly, this book also delineates a way forward via a shift from the discredited cell-kill approach of the past to an integrated, evidence-driven cancer control paradigm based on prevention, early diagnosis, and pharmacogenomics. The author's views are based on data published in mainstream scientific journals and other reliable references, 432 of which are cited. 
650 0 |a Medicine. 
650 0 |a Cancer research. 
650 0 |a Human genetics. 
650 0 |a Molecular biology. 
650 0 |a Oncology. 
650 1 4 |a Biomedicine. 
650 2 4 |a Cancer Research. 
650 2 4 |a Oncology. 
650 2 4 |a Molecular Medicine. 
650 2 4 |a Medicine/Public Health, general. 
650 2 4 |a Human Genetics. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9781402086205 
856 4 0 |u http://dx.doi.org/10.1007/978-1-4020-3617-0  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)